BR0113745A - Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina - Google Patents
Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacinaInfo
- Publication number
- BR0113745A BR0113745A BR0113745-0A BR0113745A BR0113745A BR 0113745 A BR0113745 A BR 0113745A BR 0113745 A BR0113745 A BR 0113745A BR 0113745 A BR0113745 A BR 0113745A
- Authority
- BR
- Brazil
- Prior art keywords
- vaccine
- methods
- preparing
- diagnostic test
- immunizing mammals
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 6
- 238000002405 diagnostic procedure Methods 0.000 title abstract 4
- 241000124008 Mammalia Species 0.000 title abstract 3
- 230000003053 immunization Effects 0.000 title abstract 2
- 241000713666 Lentivirus Species 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 241000713730 Equine infectious anemia virus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 208000007502 anemia Diseases 0.000 abstract 1
- 230000004069 differentiation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65902900A | 2000-09-09 | 2000-09-09 | |
PCT/US2001/027599 WO2002020049A2 (fr) | 2000-09-09 | 2001-09-06 | Vaccin chimere contre le virus de l'anemie infectieuse equine et diagnostic |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0113745A true BR0113745A (pt) | 2004-03-02 |
Family
ID=24643739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0113745-0A BR0113745A (pt) | 2000-09-09 | 2001-09-06 | Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1345622A2 (fr) |
JP (1) | JP2004522697A (fr) |
AU (2) | AU2001287103B2 (fr) |
BR (1) | BR0113745A (fr) |
WO (1) | WO2002020049A2 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3873690A (en) * | 1974-01-23 | 1975-03-25 | Iii James H Rand | Equine infectious anemia vaccine |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5955342A (en) * | 1994-08-15 | 1999-09-21 | Connaught Laboratories Limited | Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
AU7332198A (en) * | 1997-03-06 | 1998-09-22 | Klaus Uberla | Lentivirus based vector and vector system |
EP0981636B1 (fr) * | 1997-05-13 | 2005-03-23 | University Of North Carolina At Chapel Hill | Vecteurs de transfert de gene comportant un lentivirus |
CN1322137C (zh) * | 1997-12-22 | 2007-06-20 | 牛津生物医学(英国)有限公司 | 基于马传染性贫血病毒(eiav)的逆转录病毒载体 |
CN1173036C (zh) * | 1999-04-21 | 2004-10-27 | 卫生部艾滋病预防与控制中心 | 马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列 |
-
2001
- 2001-09-06 EP EP01966602A patent/EP1345622A2/fr not_active Withdrawn
- 2001-09-06 AU AU2001287103A patent/AU2001287103B2/en not_active Ceased
- 2001-09-06 WO PCT/US2001/027599 patent/WO2002020049A2/fr active Application Filing
- 2001-09-06 JP JP2002524532A patent/JP2004522697A/ja not_active Withdrawn
- 2001-09-06 AU AU8710301A patent/AU8710301A/xx active Pending
- 2001-09-06 BR BR0113745-0A patent/BR0113745A/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2001287103B2 (en) | 2007-02-01 |
JP2004522697A (ja) | 2004-07-29 |
AU8710301A (en) | 2002-03-22 |
EP1345622A2 (fr) | 2003-09-24 |
WO2002020049A2 (fr) | 2002-03-14 |
WO2002020049A3 (fr) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brownlie et al. | Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine virus diarrhoea virus | |
Tarradas et al. | Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs | |
Mondal et al. | Maternal antibody to infectious bronchitis virus: its role in protection against infection and development of active immunity to vaccine | |
Njaa et al. | Diagnosis of persistent bovine viral diarrhea virus infection by immunohistochemical staining of formalin-fixed skin biopsy specimens | |
Meyling | Detection of BVD virus in viremic cattle by an indirect immunoperoxidase technique | |
ATE131067T1 (de) | Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose. | |
McFerran et al. | Further studies on the classification of fowl adenoviruses | |
BRPI0712558A2 (pt) | determinante de virulÊncia dentro da glicoproteÍna estrutural e2 do vÍrus da febre clÁssica | |
Barrera et al. | Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats | |
Popa et al. | Complex patterns of tooth replacement revealed in the fruit bat (Eidolon helvum) | |
McNulty et al. | Applications of immunofluorescence in veterinary viral diagnosis | |
Pearson | Hog cholera diagnostic techniques | |
BR0113745A (pt) | Vacina, teste diagnóstico e métodos para imunizar mamìferos e para preparar uma vacina | |
De las Heras et al. | Enzootic nasal adenocarcinoma in sheep: An update | |
CZ20022554A3 (cs) | ®ivý oslabený virus PRRS, nukleotidová sekvence a farmaceutický prostředek | |
Downie et al. | Smallpox and related virus infections in man | |
Kim et al. | Characterization of encephalomyocarditis virus isolated from aborted swine fetuses | |
Escorcia et al. | Characterization of Mexican strains of avian infectious bronchitis isolated during 1997 | |
BR0308620A (pt) | Fragmentos de antìgenos para a diagnose de toxoplasma gondii | |
Sulkin et al. | Studies On Q Fever: Persistence of Complement-Fixing Antibodies After Naturally Acquired Infection. | |
Ghorani et al. | Detection of avian encephalomyelitis virus in broiler chickens in Iran using RT-PCR and histopathological methods | |
Becerra et al. | Studies on the response of ewes to live chlamydiae adapted to chicken embryos or tissue culture. | |
Schnackel et al. | Modified-live bovine viral diarrhea virus (BVDV) type 1a vaccine provides protection against fetal infection after challenge with either type 1b or type 2 BVDV | |
Mayaki et al. | Detection of IgG and/or IgM antibodies against equine infectious anaemia virus (EIAV) in Nigerian race and polo horses | |
Sander et al. | Protection by a commercial Arkansas-type infectious bronchitis virus vaccine against a field isolate of the same serotype |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: INTERVET INTERNATIONAL B.V. (NL) Free format text: TRANSFERIDO DE: AKZO NOBEL N.V. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06G | Technical and formal requirements: other requirements [chapter 6.7 patent gazette] |
Free format text: ANALISANDO-SE O PROCESSO REFERENTE AO PEDIDO PI0113745-0 , OBSERVA-SE QUE NAO FORAM APRESENTADOS DOCUMENTOS DE CESSAO DOS DIREITOS RELATIVOS AOS DOCUMENTOS DE PRIORIDADE PARA QUATRO INVENTORES DO PEDIDO. SOMENTE SE OBSERVA DOCUMENTO DE CESSAO OS DIREITOS RELATIVOS AOS DOCUMENTOS DE PRIORIDADE PARA DOIS INVENTORES (KRISTINA J. HENNESSEY E KAREN K. BROWN) ATRAVES DA PETICAO NO023842 DE 06/05/2003. DESTE MODO, A REQUERENTE DEVERA, PARA QUE SE DE INICIO AO EXAME, APRESENTAR COPIA DOS REFERIDOS DOCUMENTOS, SANANDO TAL IRREGULARIDADE. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2166 DE 10/07/2012. |